tadalafil has been researched along with estradiol 3-benzoate in 1 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (estradiol 3-benzoate) | Trials (estradiol 3-benzoate) | Recent Studies (post-2010) (estradiol 3-benzoate) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 1,051 | 79 | 338 |
Protein | Taxonomy | tadalafil (IC50) | estradiol 3-benzoate (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.065 | |
Glucocorticoid receptor | Homo sapiens (human) | 5.074 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 5.074 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.01 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 5.074 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 5.074 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 5.074 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.672 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbaszadeh Hasiri, M; Ahrari Khafi, MS; Dearakhshandeh, N; Golchin-Rad, K; Mogheiseh, A; Nazifi, S | 1 |
1 trial(s) available for tadalafil and estradiol 3-benzoate
Article | Year |
---|---|
Changes in the oxidative stress factors and inflammatory proteins following the treatment of BPH-induced dogs with an anti-proliferative agent called tadalafil.
Topics: Androgens; Animals; Contraceptive Agents, Hormonal; Dog Diseases; Dogs; Estradiol; Gene Expression Regulation; Inflammation; Male; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Testosterone | 2019 |